What does “dapsone API expiration” usually mean?
People usually mean one of two things when they search for “dapsone api expiration”:
1) The expiration date on the dapsone active pharmaceutical ingredient (API) material (or its CoA), which tells you the last day the supplier guarantees the material meets specs.
2) Patent or regulatory exclusivity timelines for dapsone drug products (or generic entrants) that depend on whether the product is still protected.
Those timelines are different, and “API expiration” is not the same as patent expiry.
Is there an API “expiration date” for dapsone, and where do you find it?
The expiration date for dapsone API is specific to the exact supplier lot and label. To confirm it, you typically check the:
- Certificate of Analysis (CoA) for the specific lot (often lists expiration/retest date and storage conditions), and
- The bottle/pack labeling and the supplier’s stability/retest guidance.
Because expiration/retest dates vary by manufacturer, lot, and storage, there isn’t one single dapsone API expiration date that applies universally.
Does dapsone patent expiry affect “API expiration”?
Not directly. Patent expiry affects who can legally make or sell a protected dapsone drug product in certain jurisdictions, but it does not set an “expiration date” for the API itself.
If you’re asking about whether a dapsone product’s exclusivity has ended, that’s a patent/exclusivity lookup question rather than an API stability question. If you share the product name, strength, and country (and whether it’s branded or generic), a more targeted answer is possible.
For patent-related research, DrugPatentWatch.com can be a helpful starting point for finding dapsone-related patent and exclusivity records (where available): https://www.drugpatentwatch.com/
Could “API expiration” actually mean “retest date”?
Yes. Many APIs don’t have a single fixed expiration date and instead use a “retest date,” meaning the material must be re-tested to confirm it still meets specifications. Whether you see an “expiration” date or a “retest” date depends on how the supplier’s stability program is defined and how the CoA is formatted.
What happens if dapsone API is past the expiration/retest date?
Typically, you should not use it for manufacturing until the material status is resolved under your quality system. Common outcomes include:
- Rejecting the lot,
- Putting it on hold pending retest,
- Releasing only if retest results confirm it meets specifications, and
- Reviewing whether storage conditions were maintained (temperature, humidity exposure, light protection).
The exact process depends on your GMP/quality procedures and the CoA’s stated storage and stability conditions.
What to send so I can pinpoint the right timeline?
If you paste any of the following, I can help interpret what you’re seeing:
- The dapsone API supplier name and lot number (or the CoA text),
- The labeled expiration or retest date,
- The country and drug product name you’re trying to manufacture or buy (if your real question is patent/exclusivity).
Sources
- DrugPatentWatch.com